Jefferies Starts Patheon Holdings (PTHN) at Buy; Sees Broad Platform Leading to Higher Growth
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Credit Suisse Starts Patheon Holdings (PTHN) at Neutral
August 16, 2016 6:56 AM EDTCredit Suisse initiated coverage on Patheon Holdings (NYSE: PTHN) with a Neutral rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Patheon Holdings click here. For more ratings news on Patheon Holdings click here.
Shares of Patheon Holdings closed at $27.56 yesterday.
... MoreUPDATE: Evercore ISI Starts Patheon Holdings (PTHN) at Buy
August 16, 2016 6:55 AM EDT(Updated - August 16, 2016 7:09 AM EDT)
Evercore ISI initiated coverage on Patheon Holdings (NYSE: PTHN) with a Buy rating and a price target of $33. Analyst Ross Muken anticipates growth.
"We are expanding our coverage of the Life Sciences Tools, & Diagnostics universe... More
UBS Starts Patheon Holdings (PTHN) at Buy
August 16, 2016 6:54 AM EDTUBS initiated coverage on Patheon Holdings (NYSE: PTHN) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Patheon Holdings click here. For more ratings news on Patheon Holdings click here.
Shares of Patheon Holdings closed at $27.56 yesterday.
... MorePiper Jaffray Starts Patheon Holdings (PTHN) at Overweight
August 15, 2016 7:44 AM EDTPiper Jaffray initiates coverage on Patheon Holdings (NYSE: PTHN) with a Overweight rating and a price target of $32.50.
Patheon offers its global pharmaceutical clients a single-source solution that spans the entire continuum of a drugs lifecycle, from formulation development to clinical and commercial-scale manufacturing, packaging and lifecycle management across both small and large molecule products. Its wide range and scale delivers... More
Raymond James Starts Patheon Holdings (PTHN) at Outperform
August 15, 2016 7:34 AM EDTRaymond James initiated coverage on Patheon Holdings (NYSE: PTHN) with an Outperform rating and a price target of $32.50.
For an analyst ratings summary and ratings history on Patheon Holdings click here. For more ratings news on Patheon Holdings click here.
Shares of Patheon Holdings closed at $27.00 yesterday.
... More